SVB Securities Global Biopharma Conference
- February 16, 2023
- 8:00 am
- Publications
READ MORE
- September 25, 2024
Entera Bio and OPKO Health Provide Update on PK/PD Results of Oral Oxyntomodulin (GLP-1/Glucagon) Peptide Tablet Candidate for Obesity and Metabolic Disorders
- August 20, 2024
Entera Bio to Participate in Upcoming Investor and Scientific Conferences – HCW, ASBMR, and Evercore
- August 20, 2024
